University Of Birmingham

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: Private

Established: 1900-05-01

Employees: 5K

Market Cap: -

Website: http://www.general.bham.ac.uk

Clinical Trials

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Phase 2

Active, not recruiting

Conditions: Acute Myeloid Leukaemia
High-risk Myelodysplastic Syndrome

Interventions: Drug: Fludarabine
Drug: Cytarabine
Drug: Vyxeos
Drug: Busulphan
Drug: Thiotepa

First Posted Date: 2020-01-03

Last Posted Date: 2023-05-10

Lead Sponsor: University of Birmingham

Target Recruit Count: 333

Registration Number: NCT04217278

Locations: 🇬🇧
King's College Hospital, London, United Kingdom
🇬🇧
Nottingham City Hospital, Nottingham, United Kingdom
🇬🇧
Manchester Royal Infirmary, Manchester, United Kingdom

and more 11 locations

Smoking Cessation in the Surgical Pathway Before Major Lung Surgery

Not Applicable

Conditions: Smoking Cessation
Thoracic Surgery

Interventions: Behavioral: Integrated Behavioural therapy
Drug: Integrated Pharmacotherapy
Device: Integrated Web-based application

First Posted Date: 2019-12-09

Last Posted Date: 2020-01-06

Lead Sponsor: University of Birmingham

Target Recruit Count: 120

Registration Number: NCT04190966

Effects of LDX on Cognitive Processes and Appetite

Not Applicable

Terminated

Conditions: Binge Eating
Eating Behavior

Interventions: Drug: Placebo oral tablet
Drug: Lisdexamfetamine Dimesylate

First Posted Date: 2019-12-02

Last Posted Date: 2020-11-06

Lead Sponsor: University of Birmingham

Target Recruit Count: 22

Registration Number: NCT04181957

Locations: 🇬🇧
University of Birmingham, Birmingham, United Kingdom

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

Phase 3

Active, not recruiting

Conditions: Acute Myeloid Leukemia
Myelodysplasia

Interventions: Drug: Matched placebo
Drug: Oral azacitidine

First Posted Date: 2019-11-22

Last Posted Date: 2024-05-14

Lead Sponsor: University of Birmingham

Target Recruit Count: 326

Registration Number: NCT04173533

Locations: 🇬🇧
Addenbrooke's Hospital, Cambridge, United Kingdom
🇬🇧
University Hospital Bristol, Bristol, United Kingdom
🇬🇧
Queen Elizabeth University Hospital, Glasgow, United Kingdom

and more 17 locations

Predict&Prevent: Use of a Personalised Early Warning Decision Support System to Predict and Prevent Acute Exacerbations of COPD

Not Applicable

Active, not recruiting

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Other: Usual care
Device: COPDPredict mobile App

First Posted Date: 2019-10-23

Last Posted Date: 2022-11-01

Lead Sponsor: University of Birmingham

Target Recruit Count: 384

Registration Number: NCT04136418

Locations: 🇬🇧
University Hospitals Coventry & Warwickshire Trust, Coventry, England, United Kingdom

NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer

Active, not recruiting

Conditions: Breast Cancer

First Posted Date: 2019-10-08

Last Posted Date: 2024-05-14

Lead Sponsor: University of Birmingham

Target Recruit Count: 72

Registration Number: NCT04118192

Locations: 🇬🇧
Royal Marsden Hospital, London, United Kingdom
🇬🇧
Borders General Hospital, Melrose, United Kingdom
🇬🇧
Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom

and more 21 locations

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

Phase 3

Recruiting

Conditions: Polycythemia Vera

Interventions: Drug: Ruxolitinib
Drug: Hydroxycarbamide
Drug: Interferon-Alpha

First Posted Date: 2019-10-04

Last Posted Date: 2024-11-18

Lead Sponsor: University of Birmingham

Target Recruit Count: 586

Registration Number: NCT04116502

Locations: 🇬🇧
Royal United Hospital, Bath, United Kingdom
🇬🇧
Belfast City Hospital, Belfast, United Kingdom
🇬🇧
Southmead Hospital, Bristol, United Kingdom

and more 44 locations

CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

Phase 3

Active, not recruiting

Conditions: Oropharyngeal Cancer

Interventions: Drug: Cisplatin
Procedure: Radiotherapy
Drug: Durvalumab

First Posted Date: 2019-10-04

Last Posted Date: 2024-07-29

Lead Sponsor: University of Birmingham

Target Recruit Count: 785

Registration Number: NCT04116047

Locations: 🇬🇧
Colchester General Hospital, Colchester, Essex, United Kingdom
🇬🇧
James Cook University Hospital, Middlesbrough, North Yorkshire, United Kingdom
🇬🇧
Aberdeen Royal Infirmary, Aberdeen, United Kingdom

and more 35 locations

Paediatric Early Rehabilitation/Mobilisation During InTensive Care

Conditions: Critical Illness
ICU

First Posted Date: 2019-10-01

Last Posted Date: 2019-10-01

Lead Sponsor: University of Birmingham

Target Recruit Count: 150

Registration Number: NCT04110938

Locations: 🇬🇧
Birmingham Women's and Children's Hospital PICU, Birmingham, West Midlands, United Kingdom

Trial Using CogWatch for Tea Making Training in Stroke Apraxia and Action Disorganisation Syndrome

Not Applicable

Completed

Conditions: Apraxias
Stroke

Interventions: Behavioral: Task model (CogWatch)

First Posted Date: 2019-08-05

Last Posted Date: 2019-08-07

Lead Sponsor: University of Birmingham

Target Recruit Count: 29

Registration Number: NCT04044911

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy